Main Content

“2020health is an important and thoughtful contributor to the health debate”

Dr Sarah Wollaston MP, Chairman, Health Select Committee

 
 

August

BBC Radio Kent The future of IVF treatment in the NHS,

Julia argues that decisions made in isolation about what should and shouldn’t be funded on the NHS, which vary from region to region, are not fair or democratic. IVF is a treatment which is provided on this basis and this is not fully explained to the public. Nor is it fully explained that the NHS has a finite budget, and that if money is spent providing a service in one area, such as IVF, this is taking money away from another area of service provision. read on The future of IVF treatment in the NHS,

Mail Online NHS recruits thousands of doctors from Third World... while limits on places deny British students chance to study medicine

- Health Service is hiring one third of its doctors from 143 different nations
- Government quotas mean straight-A students are being turned away from medical degrees
- Those who trained outside EU have to pass language test and medical exam
read on NHS recruits thousands of doctors from Third World... while limits on places deny British students chance to study medicine

The Telegraph 5,000 NHS patients put up in hotels

NHS hospitals have been accused of wasting money and putting lives at risk by putting up almost 5,000 patients in hotels. read on 5,000 NHS patients put up in hotels

ITV Daybreak NHS Tourism

NHS Tourism

Every year the NHS spends millions of pounds providing healthcare to foreigners who come to the UK specifically to get treatment they can’t get, or couldn’t afford, at home. The government has said they want to crack down on this.

Julia Manning highlighted that we currently don’t know how much is being spent on NHS tourists. It is likely to be a much larger proportion of the NHS budget than is currently estimated. We must remember that we have a finite NHS budget which is being put under growing strain to meet the needs of our own population.
read on NHS Tourism

PharmaTimes BIA says UK price plans 'will damage biotech'

The UK's plan for a new statutory pricing scheme for branded medicines could put future investments in the biotech sector at risk, says the Bioindustry Association (BIA).

The Department of Health plans to make the transition to a value-based pricing (VBP) scheme in 2014, with the National Institute for Health and Care Excellence (NICE) responsible for assessing the price of new drugs under the National Health Service, taking into account variables such as wider societal benefits and burden of illness.
read on BIA says UK price plans 'will damage biotech'

Comment Berwick Review into patient safety

Berwick Review into patient safety

Following the release of Professor Don Berwick’s review into patient safety, Gail Beer, Director of Operations at 2020health comments: read on Berwick Review into patient safety